APA

Yousef S., Kovacsovics-Bankowski M., Salama M. E., Bhardwaj N., Steinbach M., Langemo A., Kovacsovics T., Marvin J., Binder M., Panse J., Kröger N., Luetkens T. & Atanackovic D. (20160509). CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. : Human vaccines & immunotherapeutics.

Chicago

Yousef Sara, Kovacsovics-Bankowski Magdalena, Salama Mohamed E, Bhardwaj Neelam, Steinbach Mary, Langemo Amanda, Kovacsovics Tibor, Marvin James, Binder Mascha, Panse Jens, Kröger Nicolaus, Luetkens Tim and Atanackovic Djordje. 20160509. CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. : Human vaccines & immunotherapeutics.

Harvard

Yousef S., Kovacsovics-Bankowski M., Salama M. E., Bhardwaj N., Steinbach M., Langemo A., Kovacsovics T., Marvin J., Binder M., Panse J., Kröger N., Luetkens T. and Atanackovic D. (20160509). CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. : Human vaccines & immunotherapeutics.

MLA

Yousef Sara, Kovacsovics-Bankowski Magdalena, Salama Mohamed E, Bhardwaj Neelam, Steinbach Mary, Langemo Amanda, Kovacsovics Tibor, Marvin James, Binder Mascha, Panse Jens, Kröger Nicolaus, Luetkens Tim and Atanackovic Djordje. CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. : Human vaccines & immunotherapeutics. 20160509.